WASP (WAS)
(Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS))
Spezies
Human, Maus, Ratte, Hund
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunogen (Imm)
Sequenz
SPADKKRSGK KKI
Produktmerkmale
The peptide was used in the production of ABIN369910 - Goat Anti-Wiskott-Aldrich Syndrome / WASP Antibody. It is currently untested in blocking applications.
When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
Buffer
100µg of Lyophilised peptide, formulation De-ionized (DI) water.
Lagerung
-20 °C
Informationen zur Lagerung
Shipped at ambient temperature, store at -20°C.
Target
WASP (WAS)
(Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS))
Synonyme
IMD2 Peptide, SCNX Peptide, THC Peptide, THC1 Peptide, WASP Peptide, U42471 Peptide, WASp Peptide, Wasp Peptide, imd2 Peptide, thc Peptide, thc1 Peptide, was Peptide, wasp Peptide, wu:fk81c08 Peptide, zgc:64164 Peptide, Wiskott-Aldrich syndrome Peptide, neural Wiskott-Aldrich syndrome protein Peptide, wiskott-aldrich syndrome protein Peptide, Wiskott-Aldrich syndrome L homeolog Peptide, Wiskott-Aldrich syndrome (eczema-thrombocytopenia) b Peptide, WAS Peptide, LOC5578888 Peptide, CpipJ_CPIJ006699 Peptide, Was Peptide, was.L Peptide, wasb Peptide